Cargando…
Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox
INTRODUCTION: Monkeypox was originally endemic locally in West Africa; however, outbreaks in non-endemic countries have been recognised since May 2022. The effectiveness of tecovirimat has been estimated against smallpox, which belongs to the same Orthopoxvirus genus as monkeypox. Thus, tecovirimat...
Autores principales: | Suzuki, Tetsuya, Saito, Sho, Tsuzuki, Shinya, Ashida, Shinobu, Takakusaki, Mizue, Yoshikawa, Tomoki, Shimojima, Masayuki, Ebihara, Hideki, Ohmagari, Norio, Morioka, Shinichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394549/ https://www.ncbi.nlm.nih.gov/pubmed/37527886 http://dx.doi.org/10.1136/bmjopen-2022-069550 |
Ejemplares similares
-
Treatment with tecovirimat of the first two cases of monkeypox in Japan
por: Inada, Makoto, et al.
Publicado: (2023) -
Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection
por: Fatima, Maurish, et al.
Publicado: (2023) -
Tecovirimat for monkeypox
por: Halani, Sheliza, et al.
Publicado: (2022) -
Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study
por: Tomita, Noriko, et al.
Publicado: (2023) -
Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects
por: Das, Tuyelee, et al.
Publicado: (2023)